Overcoming Challenges with Pediatric Oral Solid Dose Development
If you have previously registered, please login here:
Email:
LOGIN
Live Webcasts:
Wednesday, October 3, 2012 at 3:00 PM IST (India Standard Time) and 10:00 AM EDT (Eastern Daylight Time)
Pediatric drug products require specialized consideration in formulation development. This niche field has gained attention among regulatory authorities in Europe, North America, and beyond, thereby providing new perspectives on and expectations of pharmaceutical drug formulators. Unique considerations must be addressed when formulating for this population, including excipient selection, dosage form, and patient compliance.
This webinar will provide an overview of current strategies and opportunities in pediatric oral solid dosage formulation development as well as insight into potential delivery options for this niche group. Technical advances and global regulatory expectations will be discussed, as will specifics in multidose and controlled release oral solid dose presentations. Strategies to improve compliance through palatability, inclusion of color for brand recognition, and single daily dose vs. multiple daily dose products will be presented.
Key Learning Objectives
Insights into the unique regulatory considerations to be addressed when formulating for the pediatric population
Opportunities to improve patient compliance by formulating specifically to meet niche group needs
Unique considerations, including excipient selection, dosage form and patient compliance
Moderator:
Angie Drakulich
Editorial Director
Pharmaceutical Technology
Speakers:
Dr. Jenny Walsh
Consultant and Founder Member,
European Pediatric Formulation Initiative
Former Pharmaceutical Development Team Manager,
Astra Zeneca
Kevin Hughes
Formulation Technologies Manager,
Colorcon
IMPORTANT - PLEASE READ
This is a
FREE
streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf,
sbarschdorf@advanstar.com
.
Register for this FREE Webcast!
Registration is required to attend this event. Please register now.
First Name
*
Last Name
*
Job Title
*
Organization Name
*
Organization Address
*
Organization Address 2
City
*
State or Province
*
Zip/Postal Code
*
Country
*
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Ashmore and Cartier Islands
Australia
Austria
Azerbaijan
Bahamas, The
Bahrain
Baker Island
Bangladesh
Barbados
Bassas da India
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Clipperton Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo, Democratic Republic of
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europa Island
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern and Antarctic
Gabon
Gambia, The
Gaza Strip
Georgia
Germany
Ghana
Gibraltar
Glorioso Islands
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Holy See (Vatican City)
Honduras
Hong Kong S.A.R.
Howland Island
Hungary
Iceland
India
Indonesia
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Jan Mayen
Japan
Jarvis Island
Jersey
Johnston Atoll
Jordan
Juan de Nova Island
Kazakhstan
Kenya
Kingman Reef
Kiribati
Korea, South
Kosovo
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao S.A.R.
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States
Midway Islands
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Navassa Island
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palmyra Atoll
Panama
Papua New Guinea
Paracel Islands
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia
South Sudan
Spain
Spratly Islands
Sri Lanka
Sudan
Suriname
Svalbard
Swaziland
Sweden
Switzerland
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tromelin Island
Tunisia
Türkiye
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wake Atoll
Wallis and Futuna
West Bank
Western Sahara
Yemen
Zambia
Zimbabwe
E-mail address
*
Work Phone
*
Is your company currently developing solid oral dosage forms for pediatrics populations?
*
Please select one
Yes
No
Don't know
Which platform technologies does your company typically use for pediatric formulations?
*
Please select one
Tablets
Mini-tablets
Multiparticulates
Granules or microparticles
ODT
Liquid
Other
Are Modified Release technologies on your list of formulation choices for pediatrics?
*
Please select one
Yes
No
Don't know
You must have
javascript
and
cookies
enabled to complete registration.
Please enable Cookies in your browser before registering for the webcast.
*
Denotes required.
REGISTER
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395.
Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Privacy Policy